SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene

Gene Therapy

Volumn 14, Issue 24, 2007, Pages 1731-1738

  Merron, A ^a   Peerlinck, I ^a   Martin Duque, P ^b   Burnet, J ^a   Quintanilla, M ^c   Mather, S ^d   Hingorani, M ^e   Harrington, K ^e   Iggo, R ^f   Vassaux, G ^a,g,h,i  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f UNIVERSITY OF ST ANDREWS   (United Kingdom)

^g INSERM   (France)

^h UNIVERSITÉ DE NANTES   (France)

ⁱ Institut des Maladies de l'Appareil Digestif   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN E1; ONCOLYTIC ADENOVIRUS; RNA; SODIUM IODIDE SYMPORTER; TELOMERASE;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAMERA; COLON ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KINETICS; LARYNX CARCINOMA; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT; VIRUS REPLICATION; WILD TYPE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; COLONIC NEOPLASMS; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; HUMANS; INJECTIONS, INTRALESIONAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ONCOLYTIC VIROTHERAPY; SYMPORTERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 36949007391     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303043     Document Type: Article

References (45)

1. Kaplan JM. Adenovirus-based cancer gene therapy, Curr Gene Ther 2005; 5: 595-605.
2. Woo Y, Adusumilli PS, Fong Y. Advances in oncolytic viral therapy. Curr Opin Investig Drugs 2006, 7: 549-559.
3. Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L. Mesenchymal progenitor cells as a cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006; 5: 755-766.
4. Wein LM, Wu JT, Kirn DH. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res 2003; 63 1317-1324.
5. Vassaux G, Martin-Duque P. Use of suicide genes for cancer gene therapy: study of the different approaches. Expert Opin Biol Ther 2004; 4: 519-530.
6. Dilley J, Reddy S, Ko D, Nguyen N, Rojas G, Working P et al. Oncolytic adenovirus CG7870 in combinition with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 2005, 12: 715-722.
7. Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y et al. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br J Cancer 2003, 89: 577-584.
8. Schepelmann S, Ogilvie LM, Hedley D, Friedlos F, Martin J, Scanlon I et al. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. Cancer Res 2007; 67: 4949-4955.
9. Wildner O, Morris JC, T1w role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virustk: assessment of antitumor efficacy and toxicity. Cancer Res 2000; 60: 4167-4174.
10. Lamfers ML, Fulci G, Gianni D, Tang Y, Kurozumi K, Kaur B et al. Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Mol Ther 2006, 14: 779-788.
11. Sarkioja M, Kanerva A, Salo J, Kangasniemi L, Eriksson M, Raki M et al. Noninvasive imaging for evaluation of the systemic delivery of capsid-modified, adenovirus in an orthotopic model of advanced lung cancer. Cancer 2006; 107: 1578-1598.
12. Le LP, Le HN, Dmitriev IP, Davydova, JG, Gavrikova T, Yamamoto S et al. Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling. J Natl Cancer Inst 2006; 98: 203-214.
13. Ono HA, Le LP, Davydova JG, Gavrikora T, Yamamoto M. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region. Cancer Res 2005, 65: 10154-10158.
14. Kanerva A, Zinn KR, Peng KW, Ranki T, Kangasniemi L, Chaudhuri TR et al. Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Therapy 2005; 12: 87-94.
15. Chung JK. Sodium iodide symporter: Its role in nuclear medicine. J Nucl Med 2002; 43: 1188-1200.
16. Robbins RJ, Schlumberger MJ. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma. J Nucl Med 2005; 46: 28S-37S.
17. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001; 86: 3327-3335.
18. Dadachova E, Carrasco N. The Na/I symporter (NIS): Imaging and therapeutic applications. Semin Nucl Med 2004; 34: 23-31.
19. Briat A, Vassaux G. Preclinical applicationsof imaging for cancer gene therapy. Expert Rev Mol Med 2006; 8: 1-19.
20. Vassaux G, Groot-Wassink T. In vivo noninvasive imaging for gene therapy. J Biomed Biotechnol 2003; 2: 92-101.
21. Haberkorn U, Altmann A, Eisenhut M. Functional genomics and proteomics - the role of nuclear medicine. Eur J Nucl Med Mol Imaging 2002; 29: 115-132.
22. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002; 13: 1723-1735.
23. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Keith WN, Vassaux G. Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res 2004; 64: 4906-4911.
24. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Reader AJ, Vassaux G. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 2004; 9: 436-442.
25. Faivre J, Clerc J, Gerolami R, Herve J, Longuet M, Liu B et al. Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats. Cancer Res 2004; 64: 8045-8051.
26. Marsee DK, Shen DH, MacDonald LR, Vadysirisack DD, Lin X, Hinkle G et al. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 2004; 11: 121-127.
27. Shah K, Jacobs A, Breakefield XO, Weissleder R. Molecular imaging of gene therapy for cancer. Gene Therapy 2004; 11: 1175-1187.
28. Dohan O, Carrasco, N. Advances, in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 2003; 213: 59-70.
29. Bilsland AE, Merron A, Vassaux G, Keith WN. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses. Cancer Res 2007, 67: 1299-1307.
30. Bett AJ, Prevec L, Graham FL. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 1993; 67: 5911-5912.
31. Hawkins LK, Johnson L, Bauzon M, Nye JA, Castro D, Kitzes GA et al. Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region. Gene Therapy 2001; 8: 1123-1131.
32. Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J et al. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat Biotechnol 2003; 21: 1328-1335.
33. Fessler SP, Young CS. Control of adenovirus early gene expression during the late phase of infection. J Virol 1998; 72: 4049-4056.
34. Majem M, Cascallo, M, Bayo-Puxan N, Mesia R, Germa JR, Alemany R. Control of E1A under an E2F-1 promoter insulated with the myotomc dystrophy locus ipsulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD. Cancer Gene Ther 2006; 13: 696-705.
35. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 2006, 155: 495-512.
36. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004; 103: 1641-1646.
37. Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ et al. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 2006; 44: 1465-1477.
38. Gagnebin J, Brunori M, Otter M, Juillerat-Jeanneret L, Monnier P, Iggo R. A photosensitising adenovirus for photodynamic therapy. Gene Theraphy 1999; 6: 1742-1750.
39. Homicsko K, Lukashev A, Iggo RD. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Cancer Res 2005; 65: 6882-6890.
40. Rowntree RK, Vassaux G, McDowell TL, Howe S, McGuigan A, Phylactides M et al. An element in intron 1 of the CFTR gene augments intestinal expression in vivo. Hum Mol Genet 2001; 10: 1455-1464.
41. Vassaux G, Manson AL, Huxley C. Copy number-dependent expression of a YAC-cloned human CFTR gene in a human epithelial cell line. Gene Therapy 1997; 4: 618-623.
42. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
43. Martinico SC, Jezzard S, Sturt NJ, Michils G, Teipar S, Phillips RK et al. Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors. Cancer Res 2006; 66: 8233-8240.
44. Stoll V, Calleja V, Vassaux G, Downward J, Lemoine NR. Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer. Gut 2005; 54: 109-116.
45. Wang Y, Groot-Wassink T, Lemoine NR, Vassaux G. Cellular characterization of the tropism of recombinant adenovirus for the adrenal glands. Eur J Clin Invest 2003; 33: 794-798.